9 followers
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assem... Read more
Jason Okazaki
Relay Therapeutics
1 follower
Eikon Therapeutics
1 follower
Thermo Fisher Scientific
166 followers
Formation Bio
2 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
FirstWord Group
2 followers
Merck
216 followers
Explore companies